TEVA position history
The shares of Teva Pharmaceutical Industries (TEVA) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 481,000 shares, $7.4M, 1.4% of portfolio, New
- 2025 Q2: 689,500 shares, $12M, 2.3% of portfolio, Add +43.3%
- 2025 Q3: 510,000 shares, $10M, 2.3% of portfolio, Reduce −26.0%
- 2025 Q4: 417,300 shares, $13M, 3.8% of portfolio, Reduce −18.2%
- 2026 Q1: 650,100 shares, $21M, 1.6% of portfolio, Add +55.8%
- 2026 Q2: 200,000 shares, $6.8M, 1.1% of portfolio, Reduce −69.2%
- 2026 Q3: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|